Extensive work in C9-NRE patient tissue and disease models has identified numerous overlapping and divergent cellular defects and pathological features potentially associated with these three putative C9-NRE-linked pathogenic mechanisms for ALS/FTD12–14. This evidence concerns the gene C9 and amyotrophic lateral sclerosis.